Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
APOPW was delisted on the 3rd of August, 2021.
2 hedge funds and large institutions have $61K invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
2% more capital invested
Capital invested by funds: $60K → $61K (+$1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $37K | -$20.1K | -8,865 | -31% |
|
|
CH
2
CVI Holdings
Wilmington,
Delaware
| $24K | +$28.5K | +12,570 | New |
|
APOPW Hedge Fund Activity: Q1 2018 in Review
2 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q1 2018, worth a combined $61K — up 1.7% from $60K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new APOPW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $20.1K.
- 2 institutional investors held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q1 2018, up from 1 in Q4 2017.
- Funds reported $61K of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q1 2018, up 1.7% quarter-over-quarter.
- 1 fund opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q1 2018 and 0 closed out, a net change of +1 holder.
- The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs seller in Q1 2018 was Susquehanna International Group, an estimated $20.1K sold.
Based on aggregated 13F filings for Q1 2018.